In early June, the FDA issued warnings to nine online networks that operate 53 pharmaceutical websites for marketing unapproved opioid medications, threatening police action and worse, possibly imposing embargos. For online pharmacy and nutraceutical merchants, as well as internet merchant account processors that provide the payment solutions for such, the warnings issued to those 53…